Targeting the NAD pathway as a new therapeutic strategy for high-risk leukaemia in children
This research project aims to develop a new drug, OT-82, to be tested as a viable therapeutic strategy for aggressive leukaemia in children, to ultimately improve their survival and minimise the side effects of treatment.
“OT-82 is now in clinical trial, which is very exciting. But it’s not yet in a clinical trial for kids. That’s why this grant from The Kids’ Cancer Project is timely, because the next step is for us to plan a trial in children.” – Dr Michelle Henderson, University of NSW
The Kids’ Cancer Project funding $138,179 | PdCCRS funding $453,279 | Total funding $591,458
Behind the science: Dr Michelle Henderson